LLY

Eli Lilly and Company · Healthcare · Drug Manufacturers - General
$1172.86
-3.24 (-0.28%)
Mkt Cap: 1.10T
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield0.9%
Dividend YieldN/A
Market Cap1.10T
Volume2.45M
Recent News
AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI
gurufocus.com · 2026-08-28
AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI
prnewswire.com · 2026-08-28
First Look: Nvidia, Marvell Earnings, Meta Settlement, and Fed in Focus
gurufocus.com · 2026-08-28
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk
reuters.com · 2026-08-28
FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes
prnewswire.com · 2026-08-28
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
zacks.com · 2026-08-27

Unlock the Full Deep Scan

9 AI agents analyze LLY across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →